Statins and small GTPases: Kochs postulates and chronic kidney disease

被引：3

作者：

Joles, Jaap A. ^{[1
]}

机构：

[1] Univ Med Ctr Utrecht, Dept Hypertens & Nephrol, NL-3508 GA Utrecht, Netherlands

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2008年 / 23卷 / 02期

关键词：

choronic kidney disease; HMG-CoA reductase; pleiotropic; statin;

D O I：

10.1093/ndt/gfm718

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

引用

页码：433 / 438

页数：8

共 50 条

[1] GROWTH-FACTORS IN GLOMERULONEPHRITIS [J].

ABBOUD, HE ;

SCHENA, FP ;

COHEN, JJ ;

STERZEL, RB ;

STRIKER, G ;

GESUALDO, L ;

FINE, LG ;

STRIKER, L ;

PETEN, E ;

THOMSON, N ;

CAMERON, S ;

BORSATTI, A ;

RUBINKELLY, VE ;

REMUZZI, G .

KIDNEY INTERNATIONAL, 1993, 43 (01) :252-267

[2] Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat [J].

Bauer, J ;

Parekh, N .

KIDNEY INTERNATIONAL, 2003, 63 (06) :2178-2186

[3] 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation [J].

Blanco-Colio, LM ;

Villa, A ;

Ortego, M ;

Hernández-Presa, MA ;

Pascual, A ;

Plaza, JJ ;

Egido, J .

ATHEROSCLEROSIS, 2002, 161 (01) :17-26

[4] HMG-CoA reductase inhibitors and the kidney [J].

Campese, V. M. ;

Park, J. .

KIDNEY INTERNATIONAL, 2007, 71 (12) :1215-1222

[5] HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways [J].

Chen, JC ;

Huang, KC ;

Lin, WW .

CELLULAR SIGNALLING, 2006, 18 (01) :32-39

[6] Role of circulating karyocytes in the initiation and progression of atherosclerosis [J].

Chon, H ;

Verhaar, MC ;

Koomans, HA ;

Joles, JA ;

Braam, B .

HYPERTENSION, 2006, 47 (05) :803-810

[7] Monitoring the cellular effects of HMG-CoA reductase inhibitors in vitro and ex vivo [J].

Cicha, I ;

Schneiderhan-Marra, N ;

Yilmaz, A ;

Garlichs, CD ;

Goppelt-Struebe, M .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (11) :2046-2050

[8] RhoA activation mediates phosphatidylinositol 3-knasedependent proliferation of human vascular endothelial cells: An alloimmune mechanism of chronic allograft nephropathy [J].

Coupel, S ;

Leboeuf, F ;

Boulday, G ;

Soulillou, JP ;

Charreau, B .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (09) :2429-2439

[9] Statins and renal diseases: From primary prevention to renal replacement therapy [J].

D'Amico, Giuseppe .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :S148-S152

[10] 3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy [J].

Danesh, FR ;

Sadeghi, MM ;

Amro, N ;

Philips, C ;

Zeng, LX ;

Lin, S ;

Sahai, A ;

Kanwar, YS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) :8301-8305

← 1 2 3 4 5 →